Integrative Proteomics Raises $25 Million in Private Financing | GenomeWeb

NEW YORK, Aug 1 – Canadian proteomics company Integrative Proteomics of Toronto said it has raised $25 million in a second round of private financing, bringing total funding raised since the company’s inception one year ago to $33 million.

The company’s strategic partners, Aurora Biosciences, Bruker AXS, and Bruker Daltonics, participated in the round, as did investment funds Lombard Odier Immunology Fund and HBM BioVentures of Switzerland and Genesys Capital Partners of Toronto.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.